CELL AND GENE THERAPY INNOVATION SUMMIT 2020

Meaning

“The Global Cell and Gene Therapy Market is estimated to be worth between £10 to £40 Billion by 2025”

The Annual Cell and Gene Therapy Innovation Summit is the only executive gathering committed to creating an advanced networking platform to increase innovation and collaboration within the Cell & Gene Therapy area.

Our cutting-edge programme covers critical subjects such as progress cell gene therapy manufacturing, ATMP development, scale-up and scale-out, manufacturing data, R&D, CAR-T therapies, global regulatory affairs, stem cells, cord blood, pricing & reimbursement, improving cost efficiency, commercialization, as well how to leverage innovation to convert cutting-edge research to advance cell gene therapy manufacturing.

Audience

Join up to 200 Decision Makers and attend the Exclusive CGTI Leaders Summit, benchmarking with Director-level and above leaders from areas such as:

Cell Therapy Research
Manufacturing Innovation
Global Medical Affairs
CMC
Regulatory Affairs
Regenerative Medicine
Advanced Therapy Production
Gene Therapy Development
Clinical Platform Development
Cellular Therapy Immuno-Oncology
Manufacturing and R&D
Quality Control
GMP
Cell & Tissue Therapy
Global Pricing and Market Access

Speakers

Jean-Pierre Latere - COO - Celyad SA

Emanuele Ostuni - Europe Head-Novartis Pharma AG

Katherine Seidl-Director, Oncology - Bluebird Bio

Marina Feschenko- PS-Biogen

Ajan Reginald - CEO - Celixir

Namir Hassan - CSO - Zelluna Immunotherapy

Ohad Karnieli- CEO - ATVIO Biotech Ltd.

David Sourdive-EVP-Cellectics

Themes and Topics

Perspectives on adjustments and Bio-Quality of Cell & Gene Therapy Bioprocessing
Future Enhancements of Manufacturing Technologies
Identify the Opportunities and Challenges in Advanced Therapy Manufacturing Process
Regulatory insight on ATMP Development
Leveraging Innovation to convert cutting-edge research to advance cell gene therapy manufacturing and processes
Cell, Gene and Immunotherapy Manufacturing
Automation and Cold Chain
Cell, Gene and Immunotherapy USP, DSP, PAT and Analytics
Emerging Cell Therapy Treatments
Analytical Testing and Quality Systems